The Asia Pacific Therapeutic Area Market Access Leader (TAMAL), Oncology reports to the VP, AP Market Access Head and leads regional market access and strategic pricing for a defined therapeutic area across AP. The role brings a unified AP perspective into global strategy, ensuring payer, HTA, pricing, reimbursement, policy and evidence needs are considered early in product, clinical, launch and pricing decisions. Working with Global Market Access, cross‑functional partners and Operating Company leaders, the TAMAL balances price, value, speed of access and patient reach across diverse markets, and is accountable for sustainable access outcomes, launch readiness, pricing governance, policy shaping, and regional market access talent and capabilities.

• Shape AP market access strategy and global influence: represent AP payer, HTA, pricing, reimbursement, policy and evidence priorities in global product, clinical, launch and acce...